TherapeuticsMD TXMD
NASDAQ TXMD
$2.19 +0.01 (+0.46%)
At close: Sep 18, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023)

TherapeuticsMD's (TXMD) quarterly Other Non Operating Income came in at $359000.0 in Q3 2023, up 420.54% on a YoY basis from $68967.4 in Q3 2022, and up 248.54% quarter-over-quarter from $103000.0 in Q2 2023.

Analysis

TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023) Analysis & Trends

TherapeuticsMD (TXMD) has reported Other Non Operating Income for 12 consecutive years, with $359000.0 the latest figure, recorded in Q3 2023.

  • For the quarter ending Q3 2023, Other Non Operating Income rose 420.54% year-over-year to $359000.0; the trailing twelve-month figure through Sep 2023 stood at $880000.0 (up 110.33% YoY), and the FY2022 full-year result was -$117000.0, down 143.01% from the prior year.
  • Other Non Operating Income advanced to $359000.0 in Q3 2023 per TXMD's latest filing, from $103000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $703662.0 in Q3 2019 and bottomed at -$10.1 million in Q2 2019.
  • Historically, Other Non Operating Income has averaged -$815051.8 across 5 years, with a median of $89000.0 in 2020.
  • The sharpest annual moves came in 2020 and 2022: Other Non Operating Income surged 35969.57% in 2020, then tumbled 6985.25% in 2022.
  • Over 5 years, Other Non Operating Income stood at -$368.0 in 2019, then soared by 35969.57% to $132000.0 in 2020, then slumped by 93.94% to $8000.0 in 2021, then soared by 37.5% to $11000.0 in 2022, then jumped by 3163.64% to $359000.0 in 2023.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $359000.0, $103000.0, and $407000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 TherapeuticsMD 25.35 Mn 16.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 359,000.00
Jun 30, 2023 103,000.00
Mar 31, 2023 407,000.00
Dec 31, 2022 11,000.00
Sep 30, 2022 -112,000.00
Jun 30, 2022 -16,000.00
Mar 31, 2022 -8.40 Mn
Dec 31, 2021 8,000.00
Sep 30, 2021 19,000.00
Jun 30, 2021 123,000.00
Mar 31, 2021 122,000.00
Dec 31, 2020 132,000.00
Sep 30, 2020 42,000.00
Jun 30, 2020 89,000.00
Mar 31, 2020 335,000.00
Dec 31, 2019 -368.00
Sep 30, 2019 703,662.00
Jun 30, 2019 -10.10 Mn
Mar 31, 2019 688,721.00
Dec 31, 2018 823,027.00